Z-1523-2021 Class II Ongoing
FDA device recall Z-1523-2021 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on Apr 6, 2021 and is designated Class II. Reason for recall: There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its… The recall status is ongoing. Affected quantity: 45,411 devices.
Recall details
- Product Type
- Devices
- Report Date
- May 12, 2021
- Initiation Date
- Apr 6, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45,411 devices
Product description
CRT-P Quad Models (CRT-Ps): a. Percepta CRT-P MRI: W1TR01, W1TR04, W4TR01, W4TR04 b. Serena CRT-P MRI: W1TR02, W1TR05, W4TR02, W4TR05 c. Solara CRT-P MRI: W1TR03, W1TR06, W4TR03, W4TR06. implantable medical devices used to treat arrhythmias related to bradycardia, and cardiac resynchronization therapy (CRT)
Reason for recall
There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its Recommended Replacement Time (RRT).
Distribution pattern
Worldwide
Code information
all serial numbers
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1523-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026